CATX 8-K 2026-11-09

Perspective Therapeutics, Inc. (CATX) 8-K dated 2026-11-09 — accession 0001193125-26-453708.

Perspective Therapeutics, Inc. (CATX) is a medical devices company listed on US.

CATX: Reports 3Q 2026 Results

This 8-K covers: Results of operations (Item 2.02), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported CATX revenue for 2022-12-31 was $0. Net income was -$10.8M. CATX currently screens at market cap $280.6M.

Not investment advice. The CATX SEC hub lists recent forms. The stock page is the research view.